Top-Rated StocksTop-Rated agilon health Stock Price, News & Analysis (NYSE:AGL) $11.55 +0.49 (+4.43%) (As of 12/8/2023 ET) Add Compare Share Share Today's Range$11.00▼$11.5750-Day Range$10.62▼$19.8052-Week Range$10.41▼$29.44Volume3.74 million shsAverage Volume3.41 million shsMarket Capitalization$4.69 billionP/E RatioN/ADividend YieldN/APrice Target$22.09 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media agilon health MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.89 Rating ScoreUpside/Downside91.3% Upside$22.09 Price TargetShort InterestBearish16.44% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.81Based on 7 Articles This WeekInsider TradingSelling Shares$826,950 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($0.20) to $0.04 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.16 out of 5 starsMedical Sector358th out of 932 stocksMiscellaneous Health & Allied Services, Not Elsewhere Classified Industry5th out of 7 stocks 4.4 Analyst's Opinion Consensus Ratingagilon health has received a consensus rating of Moderate Buy. The company's average rating score is 2.89, and is based on 8 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $22.09, agilon health has a forecasted upside of 91.3% from its current price of $11.55.Amount of Analyst Coverageagilon health has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 0.0 Short Interest Percentage of Shares Shorted16.44% of the float of agilon health has been sold short.Short Interest Ratio / Days to Coveragilon health has a short interest ratio ("days to cover") of 17.8, which indicates bearish sentiment.Change versus previous monthShort interest in agilon health has recently increased by 6.36%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend Yieldagilon health does not currently pay a dividend.Dividend Growthagilon health does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AGL. Previous Next 3.2 News and Social Media Coverage News Sentimentagilon health has a news sentiment score of 0.81. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.51 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 7 news articles for agilon health this week, compared to 3 articles on an average week.Search InterestOnly 10 people have searched for AGL on MarketBeat in the last 30 days. This is a decrease of -29% compared to the previous 30 days.MarketBeat Follows4 people have added agilon health to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, agilon health insiders have sold 230.51% more of their company's stock than they have bought. Specifically, they have bought $250,206.00 in company stock and sold $826,950.00 in company stock.Percentage Held by InsidersOnly 3.60% of the stock of agilon health is held by insiders. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for agilon health are expected to grow in the coming year, from ($0.20) to $0.04 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of agilon health is -52.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of agilon health is -52.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share Ratioagilon health has a P/B Ratio of 4.57. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About agilon health Stock (NYSE:AGL)agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2022, it served approximately 269,500 medicare advantage members and 89,000 Medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.Read More AGL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AGL Stock News HeadlinesDecember 7, 2023 | americanbankingnews.comagilon health (NYSE:AGL) Research Coverage Started at JMP SecuritiesDecember 6, 2023 | markets.businessinsider.comAgilon Health’s Innovative Approach and Growth Potential Affirm Buy RatingDecember 10, 2023 | DTI Trader (Ad)New CBOE “special perk” helps traders target income every weekendYou might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange. December 6, 2023 | markets.businessinsider.com8 Analysts Have This to Say About Agilon HealthDecember 3, 2023 | americanbankingnews.comJeffrey A. Schwaneke Buys 22,300 Shares of agilon health, inc. (NYSE:AGL) StockDecember 2, 2023 | americanbankingnews.comagilon health (NYSE:AGL) Shares Gap Up Following Insider Buying ActivityDecember 1, 2023 | finance.yahoo.comDirector Jeffrey Schwaneke's Strategic Purchase of Agilon Health Inc SharesNovember 22, 2023 | msn.comDeutsche Bank Downgrades Agilon Health (AGL)December 10, 2023 | DTI Trader (Ad)New CBOE “special perk” helps traders target income every weekendYou might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange. November 21, 2023 | msn.comDeutsche downgrades agilon to hold, says targets "overly optimistic"November 20, 2023 | seekingalpha.comagilon health: High Growth But Unsustainable EconomicsNovember 16, 2023 | businesswire.comPeer-Reviewed Study Finds Palliative Care Program Under agilon health’s Value-Based Model Significantly Improved Patient OutcomesNovember 13, 2023 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Zimmer Biomet Holdings (ZBH), Agilon Health (AGL) and Aeglea Biotherapeutics (AGLE)November 10, 2023 | morningstar.comAgilon Health Inc AGLNovember 6, 2023 | finance.yahoo.comagilon health, inc. (NYSE:AGL) Q3 2023 Earnings Call TranscriptNovember 4, 2023 | markets.businessinsider.comAgilon Health Inc. Maintains Buy Rating Amidst Utilization Pressures and Positive Operational PerformanceNovember 3, 2023 | msn.comHealthcare Service Provider Agilon Health Stock Is Plunging Today - Here's WhyNovember 3, 2023 | msn.comagilon health hits 52-week low after guidance cutNovember 2, 2023 | finance.yahoo.comagilon health Reports Third Quarter 2023 ResultsNovember 2, 2023 | finance.yahoo.comCompared to Estimates, Agilon (AGL) Q3 Earnings: A Look at Key MetricsNovember 2, 2023 | finance.yahoo.comAgilon Health Inc (AGL) Reports 75% Revenue Increase in Q3 2023November 1, 2023 | finance.yahoo.comagilon health Announces Sale of MDX HawaiiOctober 23, 2023 | finance.yahoo.comagilon health Reports ACO REACH Model Results for 2022 Performance YearOctober 21, 2023 | msn.comBenchmark Initiates Coverage of Agilon Health (AGL) with Buy RecommendationOctober 20, 2023 | markets.businessinsider.comAgilon Health: A High Growth Investment Opportunity in the Medicare Advantage MarketOctober 11, 2023 | finance.yahoo.comagilon health Sets Date to Report Third Quarter 2023 Financial ResultsOctober 4, 2023 | barrons.comS&P 500 Futures Rise in Premarket Trading; Liberty Formula One C, RB Global LagSee More Headlines Receive AGL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for agilon health and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/02/2023Today12/09/2023Fiscal Year End12/31/2023Next Earnings (Estimated)3/06/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Miscellaneous health & allied services, not elsewhere classified Sub-IndustryN/A SectorMedical Current SymbolNYSE:AGL CUSIPN/A CIK1831097 Webagilonhealth.com Phone562-256-3800FaxN/AEmployees747Year FoundedN/APrice Target and Rating Average Stock Price Target$22.09 High Stock Price Target$32.00 Low Stock Price Target$12.00 Potential Upside/Downside+91.3%Consensus RatingModerate Buy Rating Score (0-4)2.89 Research Coverage9 Analysts Profitability EPS (Most Recent Fiscal Year)($0.22) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-106,550,000.00 Net Margins-2.11% Pretax Margin-2.09% Return on Equity-8.18% Return on Assets-3.73% Debt Debt-to-Equity Ratio0.04 Current Ratio1.50 Quick Ratio1.50 Sales & Book Value Annual Sales$2.71 billion Price / Sales1.73 Cash FlowN/A Price / Cash FlowN/A Book Value$2.53 per share Price / Book4.57Miscellaneous Outstanding Shares406,040,000Free Float391,424,000Market Cap$4.69 billion OptionableNot Optionable Beta0.45 The Best High-Yield Dividend Stocks for 2023Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. Steven Jackson Sell (Age 57)President, CEO & Director Comp: $1.29MMr. Timothy S. Bensley (Age 63)Chief Financial Officer Comp: $831.31kMr. Girish Venkatachaliah (Age 49)Chief Technology Officer Comp: $655.04kMr. Ben Shaker (Age 40)Chief Markets Officer Comp: $715.5kMr. Veeral Desai (Age 42)Chief Strategy & Development Officer Comp: $667.58kMr. Timothy Gertsch (Age 37)VP, Controller & Chief Accounting Officer Mr. Matthew Dale Gillmor CFAVice President of Investor RelationsMs. Denise ZamoreChief Legal Officer & SecretaryMs. Claire MulhearnChief Communications & Public Affairs OfficerMr. Mat VargheseChief People OfficerMore ExecutivesKey CompetitorsSyneos HealthNASDAQ:SYNHSotera HealthNASDAQ:SHCProgynyNASDAQ:PGNYHealthEquityNASDAQ:HQYPremierNASDAQ:PINCView All CompetitorsInsiders & InstitutionsCitigroup Inc.Bought 18,532 shares on 12/6/2023Ownership: 0.006%Wellington Management Group LLPBought 3,162,094 shares on 12/1/2023Ownership: 10.176%Jeffrey A SchwanekeBought 22,300 shares on 11/29/2023Total: $250,206.00 ($11.22/share)Deutsche Bank AGSold 20,640 shares on 11/24/2023Ownership: 0.331%Walleye Trading LLCBought 8,800 shares on 11/21/2023Ownership: 0.000%View All Insider TransactionsView All Institutional Transactions AGL Stock Analysis - Frequently Asked Questions Should I buy or sell agilon health stock right now? 9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for agilon health in the last twelve months. There are currently 1 hold rating and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" AGL shares. View AGL analyst ratings or view top-rated stocks. What is agilon health's stock price target for 2024? 9 analysts have issued twelve-month price targets for agilon health's shares. Their AGL share price targets range from $12.00 to $32.00. On average, they expect the company's stock price to reach $22.09 in the next year. This suggests a possible upside of 91.3% from the stock's current price. View analysts price targets for AGL or view top-rated stocks among Wall Street analysts. How have AGL shares performed in 2023? agilon health's stock was trading at $16.14 at the start of the year. Since then, AGL stock has decreased by 28.4% and is now trading at $11.55. View the best growth stocks for 2023 here. Are investors shorting agilon health? agilon health saw a increase in short interest in November. As of November 15th, there was short interest totaling 49,330,000 shares, an increase of 6.4% from the October 31st total of 46,380,000 shares. Based on an average daily volume of 2,770,000 shares, the days-to-cover ratio is presently 17.8 days. Approximately 16.4% of the company's stock are sold short. View agilon health's Short Interest. When is agilon health's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 6th 2024. View our AGL earnings forecast. How were agilon health's earnings last quarter? agilon health, inc. (NYSE:AGL) announced its earnings results on Thursday, November, 2nd. The company reported ($0.06) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by $0.01. The company had revenue of $1.22 billion for the quarter, compared to analyst estimates of $1.14 billion. agilon health had a negative trailing twelve-month return on equity of 8.18% and a negative net margin of 2.11%. What ETFs hold agilon health's stock? ETFs with the largest weight of agilon health (NYSE:AGL) stock in their portfolio include SPDR S&P Health Care Services ETF (XHS), Fidelity Disruptive Medicine ETF (FMED), iShares U.S. Healthcare Providers ETF (IHF), Renaissance IPO ETF (IPO), Fidelity Growth Opportunities ETF (FGRO) and Global X Aging Population ETF (AGNG).RiverNorth Patriot ETF (FLDZ) and When did agilon health IPO? (AGL) raised $1 billion in an IPO on Thursday, April 15th 2021. The company issued 46,600,000 shares at a price of $20.00-$23.00 per share. J.P. Morgan, Goldman Sachs, BofA Securities, Deutsche Bank Securities and Wells Fargo Securities acted as the underwriters for the IPO and William Blair, Truist Securities and Nomura were co-managers. Who are agilon health's major shareholders? agilon health's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Morgan Stanley (11.04%), Wellington Management Group LLP (10.18%), Rock Springs Capital Management LP (2.04%), Artisan Partners Limited Partnership (1.68%), Brown Advisory Inc. (0.98%) and Charles Schwab Investment Management Inc. (0.44%). Insiders that own company stock include Benjamin Kornitzer, Benjamin Shaker, Cd&R Investment Associates Ix,, Clay Richards, Glenn Sobotka, Jeffrey A Schwaneke, Joan Danieley, John William Wulf, Michael L Smith, Steven Sell, Theodore Halkias, Timothy Gertsch and Veeral Desai. View institutional ownership trends. How do I buy shares of agilon health? Shares of AGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NYSE:AGL) was last updated on 12/10/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding agilon health, inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.